(Total Views: 76)
Posted On: 11/27/2024 9:51:47 AM
Post# of 5040

$SHPH Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
https://www.globenewswire.com/news-release/20...tient.html
https://www.globenewswire.com/news-release/20...tient.html

